MarketBeat listed Vertex, Alnylam, Regeneron, Amgen, Danaher, TG Therapeutics, and Gilead Sciences as stocks to watch.
4 reports, 2 independent
Updated Sep 23
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat listed Vertex, Alnylam, Regeneron, Amgen, Danaher, TG Therapeutics, and Gilead Sciences as stocks to watch.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Vertex Pharmaceuticals
American pharmaceutical company
-
Amgen
American multinational biopharmaceutical company
Related events
- MarketBeat listed Abbott, Eli Lilly, Pfizer, Gilead, AbbVie, and McKesson as stocks to watch on June 7, 2026.
- MarketBeat reports on Rackspace Technology, a company whose stock is listed on the Nasdaq exchange.
- MarketBeat lists several companies, including Nokia, IBM, Astera Labs, Marvell Technology, and Vertiv, as infrastructure stocks to watch today.
- AbbVie is listed on the Nasdaq stock exchange, and MarketBeat is reporting on its stock performance.
- MarketBeat provides stock rating data for Vivos Therapeutics, which is listed on Nasdaq.